Press play on chart to watch IMMU trade in real-time.
Immunomedics Inc. (Nasdaq: IMMU) brings opportunity for investors looking for a company with great fundamentals and nice risk/reward potential into end of year. As the chart shows (blue arrows) I am awaiting a buying opportunity around the blue trend line. and potential test of $20 by end of year.
From current stock price, potential risk/reward around 3.5 : 1.
Downside risk: $1.39
Upside reward: $3.50-$5
- Recent selloff after earnings showed strong support at the $11.59 level, which also made a double bottom.
- This selloff started around July, 2018. to emphasize the double bottom even more, the pullback from peak to trough retraced .618; a key level of Fibonacci support.
- MACD indicator showing strong convergence with price.
- Price above 20 day moving average.
- 5-day exponential moving average above 20 day moving average, indicating strength in trend.
Conclusion: $IMMU seems to bring opportunistic risk/ reward to investors who are sidelined. Double bottoms are significant patterns when looking for price reversal.
Tip # 11: Some investors wait to buy until after stock price crosses above moving averages such as the 20, 50, 100, and 200 day. These are key phycological levels to watch when trading and investing.
Please like and follow so I can continue giving trend analysis and trade ideas. Thank you in advance =)
Follow me on twitter or Instagram:[url=https://twitter.com/VolatilityWatch]@Volatilitywatch[/url]
Disclosure: I do not own IMMU. This is not a note to buy or sell. Please do your homework before investing.
MS Money Move and its Chief Operating Officer who is a scientist and individual investor, as well as its affiliates are not registered financial advisors. Our posts should serve as educational material to help you conduct due diligence research. Posts and articles are not directives or recommendations to invest in any security. We reserve the right to buy or sell any security for ourselves without any notification except when required by law. We are not responsible for the action of our affiliates. Investment theses may change due to the variable nature of the securities market. Because of this there is great risk when investing in stocks and options which can result is capital loss. Additionally, past performance by MS Money Moves or any security is not a predictor of future performance. Everyone should conduct their own research and due diligence before making an investment decision. We recommend you consult a financial advisor regarding any investment action.
The biotech sector is especially volatile. Stock prices may fluctuate substantially based on material or nonmaterial developments. We encourage everyone to familiarize themselves with clinical trial processes, relevant terminology, FDA/SEC rules and regulations, and the general processes of drug & therapy development/approval. Always do independent research in a security prior to investing.